Clinical Trials Directory

Trials / Conditions / Advanced Pancreatic Adenocarcinoma

Advanced Pancreatic Adenocarcinoma

12 registered clinical trials studyying Advanced Pancreatic Adenocarcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingGemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
NCT06454383
City of Hope Medical CenterPhase 1
RecruitingLOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT06073431
University of Rochester—
Active Not RecruitingZN-c3 + Gemcitabine in Pancreatic Cancer
NCT06015659
Brandon Huffman, MDPhase 2
Active Not RecruitingA Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic C
NCT06266143
Wuhan YZY Biopharma Co., Ltd.Phase 1 / Phase 2
CompletedCombining Epigenetic And Immune Therapy to Beat Cancer.
NCT04705818
Institut BergoniéPhase 2
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Trea
NCT04616534
National Cancer Institute (NCI)Phase 1
RecruitingNano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
NCT04789486
Dana-Farber Cancer InstitutePhase 1 / Phase 2
CompletedTrial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
NCT04634539
Jun Gong, MDPhase 1
Active Not RecruitingResistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Com
NCT04837118
M.D. Anderson Cancer CenterN/A
CompletedParicalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic
NCT04524702
Emory UniversityPhase 2
CompletedPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumo
NCT01576666
Novartis PharmaceuticalsPhase 1
TerminatedA Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-14
NCT01050283
Merck Sharp & Dohme LLCPhase 1